Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis
- Kristiina Rannikmäe1,
- Neshika Samarasekera1,
- Nahara Anani Martînez-Gonzâlez1,
- Rustam Al-Shahi Salman1,
- Cathie L M Sudlow1,2
- 1Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK
- 2Institute for Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
- Correspondence to Dr C L M Sudlow, Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK;
- Received 21 August 2012
- Revised 24 January 2013
- Accepted 30 January 2013
- Published Online First 2 March 2013
Background and purpose Cerebral amyloid angiopathy (CAA) is common in the ageing brain and is associated with dementia and lobar intracerebral haemorrhage. We systematically reviewed genetic associations with CAA to better understand its pathogenesis.
Methods We comprehensively sought and critically appraised published studies of associations between any genetic polymorphism and histopathologically confirmed CAA. We assessed the effects of genotype by calculating study specific and pooled odds ratios (ORs) in meta-analyses, and assessed small study bias.
Results 58 studies (6855 participants) investigated apolipoprotein E (APOE) genotype and sporadic CAA. Meta-analysis of 24 (3520 participants) of these showed an association of APOE ɛ4 with CAA (ɛ4 present vs absent, pooled OR 2.7, 95% CI 2.3 to 3.1, p<0.00001), which was dose dependent, robust to potential small study biases and occurred irrespective of dementia status. There was no significant association between APOE ɛ2 and CAA. Among 24 studies (4703 participants) of other genetic polymorphisms, there was preliminary evidence of an association with CAA of polymorphisms in the transforming growth factor β1 gene (two studies, 449 participants), translocase of outer mitochondrial membrane 40 gene (one study, 723 participants) and the complement component receptor 1 gene (one study, 544 participants). There were insufficient data to draw conclusions from 24 studies (∼200 participants) of APOE and hereditary CAA or familial Alzheimer's disease.
Conclusions There is convincing evidence for a dose dependent association between APOE ɛ4 and sporadic CAA. Further work is needed to better understand the mechanism of this association and to further investigate other genetic associations with CAA.